Cargando…
A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome
In chronic lymphocytic leukemia (CLL), an elevated glycosyltransferase UGT2B17 expression (UGT2B17(HI)) identifies a subgroup of patients with shorter survival and poor drug response. We uncovered a mechanism, possibly independent of its enzymatic function, characterized by an enhanced expression an...
Autores principales: | Wagner, Antoine, Rouleau, Michèle, Villeneuve, Lyne, Le, Trang, Peltier, Cheryl, Allain, Éric P., Beaudoin, Caroline, Tremblay, Sophie, Courtier, Fréderic, Nguyen Van Long, Flora, Laverdière, Isabelle, Lévesque, Éric, Banerji, Versha, Vanura, Katrina, Guillemette, Chantal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177405/ https://www.ncbi.nlm.nih.gov/pubmed/37174695 http://dx.doi.org/10.3390/cells12091295 |
Ejemplares similares
-
Inactivation of Prostaglandin E(2) as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia
por: Allain, Eric P., et al.
Publicado: (2019) -
Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
por: Guillemette, Chantal, et al.
Publicado: (2020) -
UGT2B17 modifies drug response in chronic lymphocytic leukaemia
por: Allain, Eric P., et al.
Publicado: (2020) -
The Glycosyltransferase Pathway: An Integrated Analysis of the Cell Metabolome
por: Audet-Delage, Yannick, et al.
Publicado: (2022) -
Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression
por: Lévesque, Eric, et al.
Publicado: (2020)